Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829718) titled 'Suzetrigine (Journavx) for Pain Management After Spine Surgery' on Sept. 14.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Ohio State University

Condition: Spine Fusion Postoperative Pain

Intervention: Drug: Suzetrigine (Journavx)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 13, 2026

Target Sample Size: 110

To know more, visit https://clinicaltrials.gov/study/NCT07829718

Published by HT Digital Content Services with permission from ...